Search results
Results From The WOW.Com Content Network
Prior to the UK's departure from the European Union in January 2021, the MHRA was part of the European system of approval. Under this system, national bodies can be the rapporteur or co-rapporteur for any given pharmaceutical application, taking on the bulk of the verification work on behalf of all members, while the documents are still sent to ...
A Covid-19 vaccine developed by Valneva has been given regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA). The UK had been due to receive 100 million doses of ...
The British Pharmacopoeia is an important statutory component in the control of medicines, which complements and assists the licensing and inspection processes of the UK's Medicines and Healthcare products Regulatory Agency (MHRA). Together with the British National Formulary (BNF), the British Pharmacopoeia defines the UK's pharmaceutical ...
In October 2024, the UK's Medicines and Healthcare products Regulatory Agency approved sugemalimab as part of a first-line combination treatment for lung cancer. [12] The approval was granted to CStone Pharmaceuticalsn under brand name Eqjubi. [13]
In a statement, the U.S. drugmaker added the go-ahead from the Medicines & Healthcare products Regulatory Agency (MHRA) would make Britain the first major market to be supplied with the drug in ...
The MHRA may not approve donanemab due to concerns regarding risk of side-effects, according to the report. Both the drugs have been approved for use in the United States.
In April 2022, Valneva COVID-19 vaccine was approved by the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA). [4] [3] United Arab Emirates. In May 2022, the company announced that Valneva COVID-19 vaccine was granted emergency use authorization from the United Arab Emirates (UAE). [17] European Union
Marketing Authorisation Application (MAA) is an application submitted by a drug manufacturer seeking marketing authorisation, that is permission to bring a medicinal product (for example, a new medicine or generic medicine) to the market.